Kurt Schulz, PhD
img_Kurt Schulz

Dr. Schulz is currently an Assistant Professor in the Department of Psychiatry at The Mount Sinai School of Medicine in New York.  He has been using functional magnetic imaging resonance (fMRI) techniques to investigate self-regulatory mechanisms in children and adolescents with ADHD, as well as the effects of pharmacological treatments on these mechanisms.  Dr. Schulz's main research interest lies in understanding the neurobiological mechanisms responsible for the developmental change, remission, and escalation of symptomatology commonly seen in childhood psychiatric disorders.

Clinical Interests:
Attention-Deficit/Hyperactivity Disorder
Disruptive Behavior Disorders
Aggressive behavior
Brain development

Languages: English, German

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Schulz did not report having any of the following types of financial relationships with industry during 2022 and/or 2023: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.